2m 2m 2m 2m 2m 2m 2m
Phibro Animal-A (PAHC)
NASDAQ
$30.86+$0.33 (+1.08%)
Price as of Jun 23, 2026 5:28 PM EDT- $654.6MMarket Cap
- 24.80%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Phibro Animal-A (PAHC)
$30.86+$0.33 (+1.08%)
PAHC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $30.53 | ||
Change | -$0.54 (-1.74%) | ||
Open | $31.07 | ||
High | $32.01 | ||
Low | $30.46 | ||
Previous Close | $31.07 | ||
Volume | 198,259 | ||
30-Day Average Volume | 336,512 | ||
1-Week Change | -4.20% | ||
1-Month Change | -7.82% | ||
1-Year Change | 24.80% | ||
3-Year Change | 142.93% | ||
5-Year Change | 20.72% | ||
Fundamentals | |||
Shares Outstanding | 21.1M | ||
Total Assets | $1.4B | ||
Market Cap | $654.6M | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $383.5M | ||
Net Income | $24.0M | ||
Free Cash Flow | $890,000.00 | ||
EBIT | $42.7M | ||
EBITDA | $55.2M | ||
Net Working Capital | $612.2M | ||
EPS | $0.59 | ||
Enterprise Value/EBITDA | 24 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 2 | ||
P/E | 53 | ||
PEG | -4 | ||
Price/Free Cash Flow | 736 | ||
Price/Operating Cash Flow | 40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 1.57% | ||
Trailing Annual Dividend Yield | 1.57% | ||
Ex-Dividend Date | 06/03/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield